All Stories

  1. 6-Shogaol Abrogates Parkinson’s Disease in Rotenone-Induced Rodents: Based on In Silico Study and Inhibiting TNF-α/NF-κB/IL-1β/MAO-B
  2. L-Arginine Potentiates Lisinopril Effects in a Model of Resistant Hyperuricemia and Hypertension in Rats through Decreasing Oxidant Stress and Downregulating Renal ACE Expression
  3. Unveiling the potency of FDA-approved oxidopamine HBr for cervical cancer regulation and replication proteins
  4. Bedeutende Innovationen in naturinspirierten intelligenten Computertechniken zur Identifizierung von Biomarkern und potenziellen therapeutischen Mitteln
  5. Beispielhafte Implikationen von naturinspirierten Berechnungsmethoden auf Therapeutika und computergestützte Arzneimittelentwicklung
  6. Cheminformatics approach for identification of N-HyMenatPimeMelly as a novel potential ligand against RAS and renal chloride channel
  7. Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: a multitargeted docking-based MM\GBSA and MD simulation study
  8. Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: A multitargeted docking-based MM\GBSA and MD Simulation Study
  9. Unveiling the multitargeted potency of Sodium Danshensu against cervical cancer: a multitargeted docking-based, structural fingerprinting and molecular dynamics simulation study
  10. Potential biomarkers in Japanese encephalitis from different hosts and geographical locations
  11. Biallelic Variants in Seven Different Genes Associated with Clinically Suspected Bardet–Biedl Syndrome
  12. Molecular docking analysis of AGTR1 antagonists
  13. Case report: A novel de novo loss of function variant in the DNA-binding domain of TBX2 causes severe osteochondrodysplasia
  14. Targeting Kaposi’s sarcoma associated herpesvirus encoded protease (ORF17) by a lysophosphatidic acid molecule for treating KSHV associated diseases
  15. Anti-Tumor Potential of Gymnema sylvestre Saponin Rich Fraction on In Vitro Breast Cancer Cell Lines and In Vivo Tumor-Bearing Mouse Models
  16. Dioxinodehydroeckol: A Potential Neuroprotective Marine Compound Identified by In Silico Screening for the Treatment and Management of Multiple Brain Disorders
  17. Consequential Innovations in Nature-Inspired Intelligent Computing Techniques for Biomarkers and Potential Therapeutics Identification
  18. Illustrious Implications of Nature-Inspired Computing Methods in Therapeutics and Computer-Aided Drug Design
  19. PheroxyPyrabenz and Carbopyrropyridin against major proteins of SARS CoV-2: a comprehensive in-silico molecular docking and dynamics simulation studies
  20. A novel biallelic variant further delineates PRDX3-related autosomal recessive cerebellar ataxia
  21. Isolation and drug susceptibility pattern of uropathogens in Saudi diabetic and non-diabetic patients with urinary tract infection
  22. Molecular docking analysis of phytochemicals with estrogen receptor alpha
  23. Oleuropein as a Potent Compound against Neurological Complications Linked with COVID-19: A Computational Biology Approach
  24. Identification of homozygous missense variant in SIX5 gene underlying recessive nonsyndromic hearing impairment
  25. Effect of rifampicin combination-regimens against multi-drug resistant strains in North India
  26. Brain-Derived Neurotrophic Factor: A Connecting Link Between Nutrition, Lifestyle, and Alzheimer’s Disease
  27. Case Report: Biallelic Variant in the tRNA Methyltransferase Domain of the AlkB Homolog 8 Causes Syndromic Intellectual Disability
  28. Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: anin-silicostudy
  29. In-silico Screening and Identification of Novel Trypanothione Reductase Inhibitor from Leishmania
  30. Targeting Cytotoxin-Associated Antigen A, a Virulent Factor of Helicobacter pylori-Associated Gastric Cancer: Structure-Based In Silico Screening of Natural Compounds
  31. Sodium-glucose Cotransporter-2 Inhibitors as Modulator of Dipeptidyl Peptidase-4 in Diabetes
  32. Effect of sequential eradication therapy on serum osteoprotegerin levels in patients with Helicobacter pylori infection and co-existing inflammatory bowel disease
  33. Blood Levels of Glutamine and Nitrotyrosine in Patients with Chronic Viral Hepatitis
  34. Identification of Potent Natural Resource Small Molecule Inhibitor to Control Vibrio cholera by Targeting Its Outer Membrane Protein U: An In Silico Approach
  35. A Novel Homozygous Missense Mutation in the Zinc Finger DNA Binding Domain of GLI1 Causes Recessive Post-Axial Polydactyly
  36. Targeted exome sequencing identified a novel frameshift variant in the PGAM2 gene causing glycogen storage disease type X
  37. Biallelic variant in DACH1, encoding Dachshund Homolog 1, defines a novel candidate locus for recessive postaxial polydactyly type A
  38. Computational Screening of Natural Compounds for the Discovery of Potential Aromatase Inhibitors: A Promising Therapy for Estrogen-Dependent Breast Cancer
  39. Correction to: Protective effect of 6-paradol in acetic acid-induced ulcerative colitis in rats
  40. Protective effect of 6-paradol in acetic acid-induced ulcerative colitis in rats
  41. Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate
  42. Variants in the <b><i>PNPLA1</i></b> Gene in Families with Autosomal Recessive Congenital Ichthyosis Reveal Clinical Significance
  43. Nanotechnology-based approaches in the fight against SARS-CoV-2
  44. Is Urinary Calprotectin a Useful Tool to Detect the Therapeutic Control of Type II Diabetes?
  45. Subdiuretic dose of furosemide enhances albuterol effects in asthmatic mice rather than bumetanide
  46. Effects of Candesartan and Losartan on Thioacetamide Induced Low Grade Renal Dysfunction in Rats
  47. Anti-diabetic drug utilization patterns in a government hospital in Saudi Arabia
  48. Pharmacotherapy of schizophrenia: toward a metabolomic-based approach
  49. Genetic variability might be a partial cause for different response to same drug
  50. Therapeutic effects of co-inhaled roflumilast or formoterol and fluticasone on asthma-induced ultrastructural changes in murine airways
  51. 15TH Annual World Congress On Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
  52. Cystic fibrosis: current therapeutic targets and future approaches
  53. Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice
  54. Evaluation of drug utilization pattern for patients of bronchial asthma in a government hospital of Saudi Arabia
  55. Effect of an SNP in SCAP Gene on Lipid-Lowering Response to Rosuvastatin in Indian Patients With Metabolic Syndrome
  56. Effect of rosuvastatin on dyslipidemia and other parameters associated with metabolic syndrome in Saudi patients
  57. New therapeutic targets: pannexins
  58. Dyslipidemic drugs in metabolic syndrome
  59. Effect of vitamin D supplementation on cold restraint induced oxidative stress in rats
  60. Knowledge, Attitudes and Practices of Bioethics among Doctors in a Tertiary Care Government Teaching Hospital in India
  61. Pharmacoenvironmentology – a component of pharmacovigilance